US Stock MarketDetailed Quotes

SRNE Sorrento Therapeutics

Watchlist
  • 0.001
  • 0.000-33.33%
15min DelayClose Dec 20 16:00 ET
441.02KMarket Cap0.00P/E (TTM)

About Sorrento Therapeutics Company

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Company Profile

SymbolSRNE
Company NameSorrento Therapeutics
Listing DateOct 25, 2013
Founded1989
CEODr. Henry Ji,PhD
MarketPink Market
Employees957
Fiscal Year Ends12-31
Address4955 Directors Place
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-203-4100
Websitehttp://sorrentotherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Henry Ji,PhD
  • Chairman of the Board, President and Chief Executive Officer
  • --
  • Elizabeth A. Czerepak
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer; Executive Vice President, Chief Business Officer and Chief Financial Officer of Scilex
  • --
  • Dr. Kim D. Janda, PhD
  • Director
  • --
  • Jaisim Shah
  • Director
  • --
  • David Jakob Lemus
  • Independent Director
  • --
  • Dorman Followwill
  • Lead Independent Director
  • --
  • Tammy Reilly
  • Independent Director
  • --
  • Dr. Yue Alexander Wu, PhD
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data